Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability by RENATA RUTCKEVISKI et al.
33
Acta Pharm. 69 (2019) 33–48 Original research paper
https://doi.org/10.2478/acph-2019-0001
Therapeutic bullfrog oil-based nanoemulsion for oral 
application: Development, characterization and stability
The aim of this study was to develop, optimize, and charac-
terize a stable therapeutic bullfrog oil based nanoemul-
sion for oral application using a rational experimental 
design approach. The optimized oral nanoemulsion con-
tained 0.2 % sodium benzoate and 0.02 % propyl-paraben 
as preservatives; 0.1 % sucralose and 0.4 % acesulfam K 
as sweeteners and 0.1 % tutti-frutti as flavoring to mask 
the unpleasant organoleptic characteristics of bullfrog 
oil. The oral O/W-nanoemulsion showed the droplet size, 
PDI, zeta potential, and pH of 410 ± 8 nm, 0.20 ± 0.02, 
–38 ± 2.5 mV, and 6.43 ± 0.05, respectively. The optimized 
oral nanoemulsion showed a milky single-phase and 
 optimal physical stability at 25 °C for 90 days. Indeed, 
higher oxidation induction time and lower formation of 
peroxides in the oral nanoemulsion were responsible for 
improving its stability. A therapeutic delivery system 
containing bullfrog oil for oral application was success-
fully developed and optimized with ideal thermo-oxida-
tive stability.
Keywords: bullfrog oil, nanoemulsion, thermo-oxidative 
stability, experimental design, oral application, thera-
peutic nanosystem
 
Nanoemulsions are widely used in the pharmaceutical and food industries owing to 
their ability to modify organoleptic and rheological properties of active compounds and 
promote the delivery of therapeutic agents (1). Emulsified systems are able to solubilize both 
polar and non-polar substances due to the arrangement consisting of small droplets of one 
liquid dispersed in another immiscible liquid (2). These colloidal dispersions are thermo-
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dynamically unstable and show a variety of instability mechanisms. In consequence, in-
creased kinetic stability can be achieved by using pharmaceutical excipients such as surfac-
tants (3). Nanoemulsion-based delivery systems encapsulating lipophilic compounds, such 
as animal oils, show the potential to improve absorption of fatty acids due to a large lipid-
-water interface (4). Furthermore, these emulsified systems are convenient as they reduce 
unpleasant animal oil smells, responsible for low patient compliance (5).
In this way, natural animal oils became an interesting alternative source for the devel-
opment of new products, thanks to their complex mixture of compounds and wide con-
sumer interest in natural products (6). Application of biotechnology in the waste manage-
ment process of the amphibian Rana catesbeiana Shaw adipose tissue, generally discarded 
during food processing, produces bullfrog oil and reduces negative environmental im-
pacts. The rich unsaturated fatty acid composition of bullfrog oil, mainly eicosapentae-
noic acid, makes it nutritionally and pharmacologically favorable for pharmaceutical ap-
plications (7). Intake of eicosapentaenoic acid (EPA; 20:5n-3) has a variety of well-established 
beneficial effects on human health in preventing and alleviating pathological conditions 
such as cardiovascular (8), allergy, inflammatory (9) and circulatory diseases (10) and in 
cancer therapy (11). Recent studies have demonstrated that a simple nanoemulsion con-
taining bullfrog oil showed anti-biofilm activity against certain microorganisms, and also 
reduced the viability of melanoma cells B16F10 (12, 13).
In a previous study, the thermo-oxidative stability of natural bullfrog oil in associa-
tion with synthetic antioxidants was analyzed due to the easy oxidation of unsaturated 
fatty acids in bulk media. Thus, the addition of butylhydroxytoluene was required to 
maintain the thermo-oxidative stability of natural oil (7). However, the large surface area 
interface during the development of a bullfrog oil based nanoemulsion can also induce 
interactions between lipids and water-soluble pro-oxidants, reducing the oil quality and 
producing harmful compounds (14). Therefore, rational thermo-oxidative approaches to 
producing bullfrog oil based colloidal dispersions should be applied while taking into 
account the physicochemical stability of the therapeutic oil loaded nanoemulsions.
In this context, the aim of the present study was to develop an original therapeutic 
bullfrog oil based nanoemulsion for oral application with higher physicochemical stabil-
ity. To achieve this goal, a rational 23 full factorial design was applied in order to obtain a 
suitable oral nanoemulsion improving its organoleptic attributes, conservation, and stability. 
Then, thermal and oxidative stabilities of the bullfrog oil based nanoemulsion were evaluated 




Bullfrog adipose tissue was provided by Asmarana Produtos Naturais (Brazil). Span® 
80 (sorbitan monooleate 80), acetic acid, chloroform and isooctane were purchased from 
Sigma Aldrich Inc. (USA). Propylene glycol, Tween® 20 (polyoxyethylene 20 sorbitan mono-
laurate), n-hexane, sodium hydroxide, potassium hydroxide, diethyl ether, hydrochloric 
acid and sodium carbonate were from VETEC (Brazil). Xanthan gum, propylparaben, 
methylparaben, sodium benzoate and flavoring came from Via Farma (Brazil). Butylated 
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hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) were provided by Labsynth 
(Brazil). Acesulfame K, aspartame and sucralose were purchased from Valdequímica 
(Brazil). All chemicals were of analytical or reagent grade and were used without further 
purification. Ultrapure water was obtained from a water purification system (Milli-Q® 
plus, USA) with resistivity and total organic carbon of 16.3 MΩ cm and 2 ppm at 25 °C, 
respectively.
Extraction and characterization of bullfrog oil
Extraction and characterization of bullfrog oil were conducted according to Rutckev-
iski et al. 2017 (10). Briefly, the bullfrog adipose tissue was heated on a hot plate at 70 ± 1 °C 
for 30 min under constant stirring (IKA®, RH basic model KT/C, Germany). The sample 
was filtered through a 0.22 µm membrane filter (Millex®, Millipore, France). The main 
bullfrog oil composition was analyzed by Gas-Chromatography Ultra equipped with an 
ITQ Tune mass selective detector (Thermo Scientific, USA) after derivatization with the 
BSTFA reagent. The GC–MS injector was set at 250 °C and the column was set at 90 °C with 
a heating ramp at 2 °C min−1 to 150 °C, then isothermal heating at 20 °C min−1 to 300 °C. The 
volume of the sample injected was 1 µL and helium (1 mL min−1) was used as the carrier 
gas.
Development of the control nanoemulsion 
The oil in water (O/W) bullfrog oil based control nanoemulsion was produced using 
the phase inversion technique according to a previous study of the pseudo-ternary phase 
diagram using the required hydrophile-lipophile balance (HLB) established at 12.1, made 
by our team (13). The choice of the surfactant blend and their ratio was also based on this 
study. Briefly, the HLB of bullfrog oil was determined based on the development of sys-
tems containing 92 % distilled water, 5 % bullfrog oil, and 3 % surfactant blends at differ-
ent ratio (Tween® 20 and Span® 80). The HLB of the surfactant blend ranged from 4.5 to 
15.5, with intervals of 1.0 (first batch) and 0.1 (second batch). The systems were physico-
chemically analyzed for 60 days and the critical HLB was established as 12.1 (13). Thereaf-
ter, a pseudo-ternary phase diagram based on the water titration method was developed 
using Tween® 20 and Span® 80 at a ratio of 6.29 : 3.71 in order to obtain the different col-
loidal phases (13). The nanoemulsion was selected from the milky single-phase region, 
with the highest oil and lower surfactant concentrations. Thus, the control nanoemulsion 
was composed of 14 % (m/m) of bullfrog oil, 6 % (m/m) of surfactant blend (Tween® 20 : 
Span® 80 63 : 37) and 80 % (m/m) of deionized water. For nanoemulsion production, aque-
ous and oily phases were heated separately at 70 °C and, thereafter, the aqueous phase was 
poured into the oil phase under constant stirring using an Ultra-Turrax® T-18 (IKA, Staufen, 
Germany) at 11,000 rpm for 10 min. The obtained nanoemulsion was cooled down at room 
temperature, and stored at 25 °C for 24 hours before characterization.
Experimental design approach to optimize the oral nanoemulsion 
A 2³ full-factorial experimental design was used to optimize the production of the oral 
bullfrog oil based nanoemulsion. All tests were randomly performed to ensure the inde-
pendence of observations and errors. All systems were prepared as described for the con-
36
R. Rutckeviski et al.: Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability, 
Acta Pharm. 69 (2019) 33–48.
 
trol nanoemulsion, with slight modifications. In the aqueous phase, 5 % (m/m) of propylene 
glycol and 0.3 % (m/m) of xanthan gum were added, while in the oily phase 0.01 % (m/m) of 
butylhydroxytoluene (BHT) was added. For the production of the oral nanoemulsion, 
three independent variables were included: flavoring (x1) (0.1 % (m/m) of tutti-frutti flavor 
or 0.1 % (m/m) of pineapple flavor), sweetener (x2) (0.4 % (m/m) of aspartame/ 0.4 % (m/m) of 
acesulfame K or 0.1 % (m/m) of sucralose/0.4 % (m/m) of acesulfame K and preservative (x3) 
(0.18 % (m/m) of methylparaben/ 0.02 % (m/m) of propylparaben or 0.2 % (m/m) of sodium 
benzoate/ 0.02 % (m/m) of propylparaben) were selected for the optimization approach. The 
experimental matrix consisted of 8 runs and each factor was studied between the lower 
(–1) and the higher (+1) level (Table I). Droplet size, zeta potential and pH were selected as 
dependent output response variables in order to obtain a small droplet, negatively charged, 
and pH-compatible for oral nanoemulsions. The effects of the studied variables were inter-
preted by the Statistic software (Version 7.0, StatSoft Inc., USA).
Characterization of nanoemulsions
Macroscopic aspect. – Macroscopic aspects (changes in color and odor) as well as im-
mediate stability (creaming index or phase separation) were evaluated by visual inspec-
tion of control and oral nanoemulsions stored in scintillation vials at 25 ± 2 °C.
pH determination. – The pH values were determined in triplicate directly in the nano-
emulsions using a pre-calibrated pH-meter (Tecnal, TEC-2, Brazil) at 25 ± 2 °C.
Conductivity determination. – Conductivity values of the nanoemulsions were deter-
mined in triplicate using a pre-calibrated conductimeter (Digimed, DM-32, Brazil) at 25 ± 
2 °C. 
Table I. Variables and levels chosen to define the experimental region and their corresponding coded values for 
the bullfrog oil oral nanoemulsion production
Independent variables Level (%, m/m)
i Xi –1 +1











Dependent variables Desired response
1 Droplet size (nm) Minimize
2 Zeta potential (mV) Maximize
3 pH Maximize
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Droplet size distribution. – The hydrodynamic diameter and the polydispersity index 
(PDI) of oil droplets were determined by dynamic light scattering (DLS) using a Zetasizer 
Nano ZS (Malvern Instruments Ltd, UK). Measurements were conducted at 25 °C and the 
samples were diluted at 1:50 with deionized water before analysis. 
Zeta potential. – Zeta potential of the nanoemulsion was deduced from the electropho-
retic mobility of the particles measured by Laser Doppler Electrophoresis, Zetasizer Nano 
ZS, at 25 °C in a NaCl solution (1 mM) after suitable dilutions (1/50 (V/V)) of the different 
nanoparticle suspensions. Values are presented as the means of measurements performed 
on three replicate samples.
Stability studies
Stability under storage (long-term stability). – Test tubes containing control and basic 
bullfrog oil based nanoemulsions were stored vertically in a hot air oven at 45 ± 2 and 25 
± 2 °C. Macroscopic aspects were evaluated weekly for 90 days, following the interna-
tional regulatory standards of the World Health Organization “Stability testing of active 
pharmaceutical ingredients and finished pharmaceutical products” (15). 
Freeze/thaw stability. – Nanoemulsions were subjected to alternate six freeze and thaw 
cycles for a period of 12 days. 10 g of nanoemulsions were stored in sealed tubes for 24 h 
in a freezer at –5 °C, followed by another period of 24 h at 45 °C according to Xavier-Júnior 
et al. (16). After each cycle, the macroscopic aspect was analyzed as described above (2.5.1.)
Stability under centrifugation. – Glass vials containing 5 g of samples were centrifuged 
at 3,000 g for 30 min at 25 °C. Nanoemulsions were evaluated visually, taking physical 
stability into account.
Oxidative stability. – Formation of primary oxidation products was monitored by for-
mation of peroxide compounds (10). To study the susceptibility to oxidation of the control 
and the oral bullfrog oil based nanoemulsions, samples were subjected to an accelerated 
oxidation test under standardized conditions. Immediately after preparation, 60 g of na-
noemulsions were placed into 125 mL flasks, which were kept sealed and subjected to the 
Schaal oven test conditions (60 °C). After that, the peroxide value, conjugated dienes and 
oxidation induction time were analyzed to determine oxidation of the bullfrog oil-based 
nanoemulsions. 
Peroxide value
3.5 g of nanoemulsions were vigorously dissolved in 35 mL of glacial acetic acid/iso-
octane (60 : 40 (V/V)). Then, 900 µL of saturated potassium iodide solution were added and 
the sample was titrated with 0.1 mol L–1 sodium thiosulfate using starch solution as indica-
tor. Peroxide value was expressed as mEq of oxygen per 1 kilogram of nanoemulsion.
Conjugated dienes
The first stage of bullfrog oil oxidation was monitored by conjugated dienes. 0.5 g of 
nanoemulsions were diluted in 4 mL of chloroform/methanol (2:1) under vigorous vortex 
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stirring for 12 min. Samples were then centrifuged at 3,500 rpm for 5 min and the organic 
phase was removed. Absorbance was measured with an N Evolution 60S UV-Vis Spectro-
photometer (Thermo Scientific, USA) at 232 nm against a blank solution of hexane.
Oxidation induction time
Oxidation induction time of the nanoemulsions was evaluated by a Rancimat® (Me-
trohm model 873, Switzerland). Samples were heated at 110 ± 1 °C under airflow of 10 L h–1. 
Volatile acid compounds produced during oxidation were analyzed in a conductivimetric 
cell containing water. Conductivity changes over time were plotted to determine the oxida-
tion induction time of the nanoemulsions.
Thermal stability
Thermal stability of the nanoemulsions was measured by DTA/TGA (DTG-60H, Shi-
madzu Corporation, Japan). Samples (2 ± 0.5 mg) were placed into aluminum pans and 
analyzed under the heating rate of 10 °C min–1, nitrogen flow of 50 mL min–1 and tempera-
ture range of 25–600 °C.
Statistical analyses
All results were expressed as mean ± standard deviation of the analysis in triplicate. 
Statistical comparisons were made using the analysis of variance (ANOVA). Comparisons 
between two groups were made by Student’s t-test. Differences were considered statisti-
cally significant at p < 0.05. Graph Pad Prism (Version 5.0, USA) software was used for 
statistical analysis of the data.
RESULTS AND DISCUSSION
Extraction and chemical composition of bullfrog oil
The bullfrog oil extraction process gave a yield of 60 ± 0.9 % (m/m) with the absence of 
solvent residues that could have negative impacts on human health (7). Bullfrog oil showed 
ideal physicochemical characteristics for the production of therapeutic nanoemulsions 
without off-flavors and with low peroxide and acidity values (7). According to the GC-MS 
analysis, the main compounds found in bullfrog oil were oleic acid (18:1 n−9) (30 %), eicos-
apentanoic acid (20:5 n−3) (17.6 %) and palmitic acid (16:0) (10.3 %). The presence of polyun-
saturated fatty acids in the oil, especially long chain compounds such as eicosapentaenoic 
acid, may explain its anti-inflammatory properties (9).
Development of bullfrog oil-based nanoemulsions
In this work, an innovative bullfrog oil based nanoemulsion with higher oil concen-
tration (14 % (m/m)) and lower concentration (6 %, m/m) of nonionic surfactants (Tween® 20/ 
Span® 80 63 : 37) was produced. Later on, this control nanoemulsion was optimized by a 
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2³ full-factorial experimental design to obtain the therapeutic oral bullfrog oil-based na-
noemulsion containing different pharmaceutical excipients.
The control bullfrog oil based nanoemulsion showed a milky single-phase system due 
to the decrease of surface tension by the surfactant mixture. Conductivity was 149.6 ± 2.9 
µS cm–1 due to the ions present in the continuous aqueous phase of the O/W nanoemul-
sion. This nanoemulsion showed a neutral pH of 6.6 ± 0.01. These parameters can influence 
the charge, solubility, partitioning, oxidative reactions, and chemical stability of com-
pounds (17). An increase of primary oxidation products (peroxides) was observed in the 
nanoemulsions stabilized with Tween 80 and sodium dodecylsulfate when decreasing the 
pH of the nanoemulsion. In addition, a low pH could promote the activation of metal ions 
responsible for promoting the oxidation process (18).
The droplet size of the control nanoemulsion was 304.6 ± 22.4 nm with PDI of 0.314 ± 
0.125. Droplet size is a crucial factor for monitoring nanoemulsion stability. In general, 
smaller droplet size produces more stable nanoemulsions, and with many sites for gastric 
lipase binding, improve the fat digestion rate (19). The nanoemulsion zeta potential was –17.2 
± 0.1, suggesting that repulsive forces predominated over the attractive ones.
Optimization of the therapeutic oral bullfrog oil based nanoemulsion
According to the results obtained for the control nanoemulsion, optimization of the 
pharmaceutical excipients used to obtain the therapeutic oral bullfrog oil based nanoemul-
sion was carried out. Three excipients at fixed concentrations, (5 % (m/m) propylene glycol, 
0.3 % (m/m) xanthan gum and 0.01 % (m/m) BHT) and a different composition of flavoring 
(x1), sweetener (x2) and preservative (x3), were added to the control bullfrog oil based 
nanoemulsion in order to produce the therapeutic oral nanoemulsion (Table I). The afore-
mentioned fixed pharmaceutical excipients were used at a concentration approved for oral 
pharmaceutical products (20). Propylene glycol acts on the solubility and dispersion of 
active substances, and it can also create a stable homogeneous nanoemulsion (20). Xanthan 
gum is an anionic heteropolysaccharide applied to enhance the viscosity of the continuous 
phase in the O/W nanoemulsion, decreasing the droplet movement and diffusion of pro-
Fig. 1. Pareto Chart of the standardized effects on droplet size (), zeta potential () and pH () in 
the formation of bullfrog oil nanoemulsions.
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oxidants responsible for the creaming and lipid oxidation (21, 22). BHT is a highly effective 
synthetic antioxidant used to control lipid oxidation (14). Nonpolar antioxidants tend to get 
localized in the oil phase and the interfacial layer, increasing its effectiveness to retard oil 
oxidation (14, 18). A previous study has also shown the BHT ability to delay bullfrog oil 
oxidation (7).
The experimental design approach was, therefore, applied to determine the best com-
bination of flavoring, sweeteners and preservatives to produce a stable oral nanoemulsion. 
All the oral nanoemulsions showed a homogeneous milky aspect, and the absence of bull-
frog oil smell. The mean hydrodynamic diameter was strongly influenced by the selected 
variables, emphasizing their relevancy as critical parameters that would influence the 
preparation process. The oral nanoemulsion size ranged from 300 to 470 nm. The Pareto 
chart gives standardized effects of the independent variables and their interactions with 
the dependent variable (Fig. 1).
The Pareto chart allows identification of the statistically significant variables needed 
to produce the nanoemulsion. Thus, the individual standardized effects of the studied 
variables and, later, their interaction effects on the size, zeta potential, and pH were ana-
lyzed. Positive value of the response of independent variables indicates an unfavorable 
increase in droplet size, or a favorable effect on the increase of the zeta potential and the 
pH value. Therefore, all first order independent variables had a significant effect on the 
droplet size, especially the preservative ingredient (p < 0.05). Effects of the preservative 
and sweetener ingredients, and their interactions, were the ones that most significantly 
influenced the formation of smaller droplet size. Sodium benzoate, when used as a preser-
vative, is an amphiphilic excipient that can act as a small chain surfactant in the nanoemul-
sion interface responsible for the formation of smaller droplet size (23). According to Hat-
zopoulous, its chemical arrangement has an important effect on the nanoemulsion 
structure, promoting the formation of cylindrical/ellipsoidal droplets (23). The sucralose 
sweetener already contains hydroxyls groups that may confer an emulsifying action, indi-
cating its tendency to be arranged in the droplet interface and improving its properties 
associated with the perception of sweetness (24).
Independent variables and their interactions were evaluated by the coefficient of de-
termination (R2), which represents the linear relationship between the observed and the 
predictive values. Thus, the matrix of the developed experiments was considered statisti-
cally significant with a linear relationship of R2 = 0.972, indicating that the model could 
explain 97.2 % of the variability in the obtained response. The adjusted determination 
coefficient (R2Adj) 0.959 confirmed the high significance of the model to droplet size analyses 
of the nanoemulsion. Therefore, this matrix of experiments ensured satisfactory adjust ment 
of the linear model to experimental data.
Aiming at straightforward examination of experimental variables in the responses, 
the three-dimensional response surfaces were drawn. Figures 2a and 2b show a three-di-
mensional diagram of the droplet size response surface relating to both the preservative 
and the sweetener (Fig. 2a), and the preservative and the flavoring (Fig. 2b). As can be seen, 
reduction of the droplet size can be achieved at a low level of flavoring and a high level of 
preservative and sweetener. Therefore, nanoemulsions with smaller droplet sizes were 
obtained with 0.2 % (m/m) of sodium benzoate and 0.02 % (m/m) of propylparaben as pre-
servatives, 0.1 % (m/m) of sucralose and 0.4 % (m/m) of acesulfame K as sweetener; and 0.1 
% (m/m) of tutti-frutti as flavoring.
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Fig. 2. Effect of the interaction between independent variables (preservative X sweetener, and preser-
vative X flavoring) on the droplet size (a, b), zeta potential (c, d) and pH (e, f).
a)                                                                         b)
c)                                                                         d)
e)                                                                         f)
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The zeta potential values ranged from –14 ± 0.8 to –30 mV ± 1.2. All independent vari-
ables had a significant effect on the zeta potential (p < 0.05) with R² = 0.93 and R2Adj = 0.90 
(Fig. 1). In addition, all samples showed negatively charged droplets, which may be due to 
the anionic character of xanthan gum and other excipients present in the formulation (21). 
Higher zeta potential of the nanoemulsion was obtained at the high level (+1) of sweetener 
and preservative, and low level (–1) of flavoring (Fig. 2c,d). Sucralose can act as a surface 
agent by exposing its hydroxyl and chlorine groups, contributing to the electrostatic po-
tential near the droplet surface, jointly with the acesulfame K and sodium benzoate (24). 
Thus, the use of an ideal pharmaceutical adjuvant may increase the ionic strength in the 
aqueous phase of the O/W nanoemulsion, affecting the electrostatic repulsion between the 
dispersed droplets and increasing the electrostatic stability of the colloidal dispersion.
The pH values were significantly influenced by all independent variables according 
to the Pareto diagram (Fig. 1) with ANOVA linear relation with R2 = 0.99 and R2Adj = 0.99. 
Preservatives and sweeteners had a significant effect on pH increase. In contrast, a low 
level of flavorings generated nanoemulsions with low pH values. Some citrus flavorings, 
such as pineapple flavor, are composed of chemically unstable esters that are prone to 
degradation during storage, thereby decreasing the pH of the nanoemulsion (3). The re-
sponse surface of interactions between the independent variables (Fig. 2e,f) showed that 
neutral pH values for the oral bullfrog oil based nanoemulsion were obtained with high 
levels of preservative and sweetener, and a low level of flavoring.
When all dependent variables were taken together, the optimal composition of the 
oral nanoemulsion would contain 0.2 % (m/m) of sodium benzoate and 0.02 % (m/m) of 
propylparaben as preservatives, 0.1 % (m/m) of sucralose and 0.4 % (m/m) of acesulfame K 
as sweeteners, and 0.1 % (m/m) of tutti-frutti as flavoring. The oral bullfrog oil based nano-
emulsion prepared under these conditions showed a final droplet size of 410 ± 8 nm, PDI 
of 0.20 ± 0.02, zeta potential of –38 ± 2.5 mV, pH of 6.43 ± 0.05 and conductivity of 1913.8 ± 
3.15 µS cm–1, indicating favorable properties for oral application.
Stability of the optimized oral nanoemulsion
Stability determination of the optimized oral nanoemulsion was important to assess 
the effect of pharmaceutical excipients on the formulation. The control nanoemulsion 
without excipients showed a creaming index of 3.2 % and phase separation after 60 and 19 
days when stored at 25 and 45 °C, respectively. The optimized oral nanoemulsion showed 
a milky single phase; fishy smell reduction, higher viscosity and physical stability at 25 °C. 
This effect can be associated with xanthan gum, which increases the viscosity of the aque-
ous phase, reducing the coalescence of oil droplets from the oral nanoemulsion (21).
The preliminary stability study allowed possible detection of short-time physical in-
stabilities in the control nanoemulsion, indicating the need for reformulation. The opti-
mized oral bullfrog oil based nanoemulsion showed no visible creaming or phase separa-
tion after centrifugation. However, the control nanoemulsion showed phase separation in 
the second freeze/thaw cycle, while the optimized oral nanoemulsion remained stable 
after 6 cycles, indicating that the presence of excipients improved its physical stability.
Influence of excipients on the pH and droplet size was investigated in control and 
optimized oral bullfrog oil based nanoemulsions (Fig. 3). After 90 days, the optimized oral 
nanoemulsion showed no significant difference in the pH value, pH of 6.43 ± 0.1, indicating 
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that the excipients were responsible for promoting good physicochemical stability (Fig. 3a). 
However, a significant pH change from 6.68 ± 0.01 to 2.97 ± 0.01 for the control nanoemul-
sion was observed. This effect can be explained by the fatty acid hydrolysis of bullfrog oil 
or by microbiological proliferation in the nanoemulsion (25). The oral nanoemulsion con-
taining excipients showed a superior droplet size (410 ± 8 nm) compared to that of the 
control nanoemulsion (305 ± 13 nm) (Fig. 3b). However, the droplet size of the oral nano-
emulsion containing excipients remained constant during the storage period at 25 °C (p > 
0.05), with lower PDI value ranging from 0.2 to 0.3, whilst the control nanoemulsion 
showed a higher value (ranging from 0.3 to 0.6). Multimodal droplet size distributions can 
be responsible for the instability of the basic nanoemulsion after storage due to the coales-
cence of droplets (26).
Zeta potential is a stability-related parameter that measures the repulsion or attraction 
magnitude of the electric charges at the interface of nanoemulsion droplets (3). Optimized 
oral bullfrog oil based nanoemulsion showed a high zeta potential ranging from –38 ± 2.5 
mV to –30 ± 0.3 mV after storage for 90 days. Although the nonionic surfactants used do 
not supply electrical charge to the oil droplet surface, the high initial zeta potential can be 
attributed to the presence of negatively charged xanthan gum, sucralose hydroxyl groups, 
and the presence of anionic free fatty acids from bullfrog oil (21, 27). In addition, owing to 
steric contribution of the compounds, they may also reduce droplet aggregation (21, 22, 28). 
Addition of pharmaceutical excipients also increased to 1913.83 ± 3.15 µS cm–1 the conduc-
tivity of the oral bullfrog oil-based nanoemulsion compared to the control nanoemulsion, 
which showed a value of 149.6 ± 2.9. In addition, no statistically significant difference was 
observed in the optimized oral nanoemulsion after storage time at 25 °C.
Fig. 3. a) pH and b) droplet size of the optimized oral (grey) and the control (light grey) nanoemulsion 
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Primary oxidation products were evaluated by the conjugated dienes and the peroxide 
value, immediately after production, and under the Schaal oven conditions at 60 °C. The 
optimized oral nanoemulsion showed conjugated dienes and peroxide value of 0.211 ± 
0.001 and 1.5 ± 0.3 mEq O2 kg
–1, respectively. However, the control nanoemulsion showed 
values of 0.393 ± 0.004 and 2.5 ± 0.1 mEq O2 kg
–1, respectively. All nanoemulsions showed 
an increase in the peroxide and conjugated dienes, indicating primary oxidative degrada-
tion of the bullfrog oil during storage (Fig. 4). This oxidation effect was two-fold higher for 
the control nanoemulsion. Addition of excipients in the optimized oral nanoemulsion was 
responsible for a significant decrease of the oxidation process compared to the control 
nanoemulsion (p < 0.05). The oxidation mechanism of polyunsaturated fatty acids in the 
nanoemulsion can be associated with the large oil droplet surface, which increases interac-
tions between the lipids and pro-oxidant compounds from the aqueous phase (14). In gen-
eral, nonpolar antioxidants such as BHT are effective in retarding oxidation in the nano-
emulsion due to their localization in the oil-water interface reducing the formation of 
primary oxidation products (29). In addition, xanthan gum can act so as to reduce the 
lipid oxidation rate in the nanoemulsion interface due to its function of chelating metal 
ions, increasing the viscosity of the aqueous phase and delaying diffusion of pro-oxidant 
molecules (oxygen or metals) in the oily phase (22).
Oxidation induction time by Rancimat® was also applied to evaluate the oxidative 
stability of emulsified bullfrog oil. Control and optimized oral nanoemulsions showed an 
Fig. 4. a) Conjugated diene values at 232 nm and b) peroxide values under the Schaal oven test for the 
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induction time of 0.25 ± 0.01 and 6.69 ± 0.15 hours, respectively. Pharmaceutical excipients 
increased 27-fold the oxidative stability of the optimized oral bullfrog oil-based nanoemul-
sion, preventing oxidation of unsaturated fatty acids from bullfrog oil. This result cor-
roborates the ones of Sotomayor-Gerding et al., who observed a 22-fold increase of the in-
duction time in the linseed oil-loaded nanoemulsion with astaxanthin and lycopene 
compared to the control nanoemulsion (30).
Fig. 5. TGA (a, b) and DTA (c) curves of nanoemulsions. Samples: (----) bullfrog oil, (––) oral nano-
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As seen in Fig. 5a, the TGA profiles of the control and the optimized oral nanoemul-
sion were divided into two mass loss events. The temperature range used in the thermal 
stability analyses was selected according to the TGA curve of bullfrog oil, which showed 
thermal decomposition products with total mass loss up to 530 °C (7). The first weight loss 
event occurred up to 135 °C, with a loss of 93 and 73 % for the control and the optimized 
oral nanoemulsion, respectively. The first weight loss occurred due to the evaporation of 
free and bound water loss with increasing temperature. The final weight change was ob-
served above 350 °C, which implies the presence of bullfrog oil and other constituents that 
degraded at higher temperatures in the nanoemulsion. In addition, the control nanoemul-
sion showed a decomposition temperature of 50 % of the sample at 68 °C, while for the 
optimized oral nanoemulsion such temperature event was settled at 83 °C (Fig. 5b). This 
behavior can be mainly attributed to the presence of different excipients in the oral nano-
emulsion, indicating the best thermal performance. In differential thermal analysis (DTA), 
one endothermic event was observed for both oral and control nanoemulsions, ranging 
from 30 to 130 °C. After dehydration, two successive exothermic events took place under 
further heating (370–470 °C), related to the thermal degradation of pharmaceutical 
additives and the bullfrog oil. However, the energy release of the exothermic reaction was 
higher for the oral nanoemulsion, which may be due to the presence of pharmaceutical 
additives.
CONCLUSIONS
Bullfrog oil was efficiently extracted and showed ideal physicochemical characteristics 
with low peroxide and acidity values. Chemical composition of bullfrog oil shows a high 
predominance of eicosapentaenoic and oleic acids. The preparation process of a thera-
peutic oral nanoemulsion composed of bullfrog oil: Tween® 20/Span® 80/water at the ratio 
of 14 : 3.8 : 2.2 : 80 by the phase inversion method was satisfactorily optimized by 23 full 
factorial design. The composition of the preservatives, sweeteners and flavoring selected 
by the factorial design was 0.2 % sodium benzoate + 0.02 % (m/m) propylparaben, 0.1 % 
(m/m) sucralose + 0.4 % (m/m) acesulfame K, and 0.1 % (m/m) tutti-frutti, respectively. Incorpo-
ra tion of bullfrog oil in an oral emulsified system improved its unpleasant organoleptic 
characteristics and increased its thermal and oxidative stability over a basic nanoemulsion. 
Finally, this research indicated that bullfrog oil proved to be suitable for the development 
of dispersed systems, due to its rich composition of bioactive compounds that allow for a 
probable therapeutic activity. This activity can be potentiated by the developed emulsified 
system, due to its capacity to improve the biopharmaceutical and pharmacokinetic properties 
of the oil and, in addition, masking its unpleasant organoleptic properties.  It is therefore 
believed that such qualities of the oral bullfrog oil nanoemulsion would enhance patient 
compliance with the treatment.
Acknowledgement. – The authors thank CAPES and CNPQ for financial support, the Asmarana 
Produtos Naturais for providing the bullfrog fatty tissue, and the Laboratory of Fuels and Lubricants 
(UFRN) for the Rancimat® analyses.
47
R. Rutckeviski et al.: Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability, 
Acta Pharm. 69 (2019) 33–48.
 
REFERENCES
 1.  J. L. Burguera and M. Burguera, Analytical applications of emulsions and microemulsions, Ta-
lanta 96 (2012) 11–20; https://doi.org/10.1016/j.talanta.2012.01.030
 2.  A. H. Saberi, Y. Fang and D. J. McClements, Fabrication of vitamin E-enriched nanoemulsions: 
Factors affecting particle size using spontaneous emulsification, J. Colloid Interface Sci. 391 (2013) 
95–102; https://doi.org/10.1016/j.jcis.2012.08.069
 3.  D. T. Piorkowski and D. J. McClements, Beverage emulsions: Recent developments in formulation, 
production, and applications, Food Hydrocoll. 42 (2014) 5–41; https://doi.org/10.1016/j.food-
hyd.2013.07.009
 4.  D. J. McClements and Y. Li, Structured emulsion-based delivery systems: Controlling the diges-
tion and release of lipophilic food components, Adv. Colloid Interface Sci. 159 (2010) 213–228; https://
doi.org/10.1016/j.cis.2010.06.010
 5.  P. Karthik and C. Anandharamakrishnan, Enhancing omega-3 fatty acids nanoemulsion stability 
and in-vitro digestibility through emulsifiers, J. Food Eng. 187 (2016) 92–105; https://doi.org/10.1016/j.
jfoodeng.2016.05.003
 6.  I. A. Nehdi, Characteristics and composition of Washingtonia filifera (Linden ex André) H. 
Wendl. seed and seed oil, Food Chem. 126 (2011) 197–202; https://doi.org/10.1016/j.food-
chem.2010.10.099
 7.  R. Rutckeviski, F. H. Xavier-Jr, A. R. V. Morais, E. N. Alencar, L. A. Machado, J. Genre, A. Gondim 
and E. S. T. Egito, Thermo-oxidative stability evaluation of Bullfrog (Rana catesbeiana Shaw) oil, 
Molecules 22 (2017) 606; https://doi.org/10.3390/molecules22040606
 8.  J. R. Nelson, O. Wani, H. T. May and M. Budoff, Potential benefits of eicosapentaenoic acid on 
atherosclerotic plaques, Vascul. Pharmacol. 91 (2017) 1–9; https://doi.org/10.1016/j.vph.2017.02.004
 9.  D. S. Kelley, Modulation of human immune and inflammatory responses by dietary fatty acids, 
Nutrition 17 (2001) 669–673; https://doi.org/10.1016/S0899-9007(01)00576-7
10.  E. Kurtys, U. L. M. Eisel, J. M. Verkuyl, L. M. Broersen, R. A. J. O. Dierckx and E. F. J. Vries, The 
combination of vitamins and omega-3 fatty acids has an enhanced anti-inflammatory effect on 
microglia, Neurochem. Int. 99 (2016) 206–214; https://doi.org/10.1016/j.neuint.2016.07.008
11.  A. M. Eltweri, A. L. Thomas, M. Metcalfe, P. C. Calder, A. R. Dennison and D. J. Bowrey, Potential 
applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastro-
intestinal cancer, Clin. Nutr. 36 (2017) 65–78; https://doi.org/10.1016/j.clnu.2016.01.007
12.  E. N. Alencar, F. H. Xavier-Jr, A. R. V. Morais, T. R. F. Dantas, N. Dantas-Santos, L. M. Verissimo, 
V. L. G. Rehder, G. M. Chaves, A. G. Oliveira and E. S. T. Egito, Chemical characterization and 
antimicrobial activity evaluation of natural oil nanostructured emulsions, J. Nanosci. Nanotechnol. 
15 (2015) 880–888; https://doi.org/10.1166/jnn.2015.9187
13.  L. Amaral-Machado, F. H. Xavier-Jr, R. Rutckeviski, A. R. V. Morais, E. N. Alencar, T. R. F. Dantas, 
A. K. M. Cruz, J. Genre, A. A. Silva-Jr, M. F. F. Pedrosa, H. A. O. Rocha and E. S. T. Egito, New 
trends on antineoplastic therapy research: Bullfrog (Rana catesbeiana Shaw) oil nanostructured 
systems, Molecules 21 (2016) 585; https://doi.org/10.3390/molecules21050585
14.  D. J. McClements and E. A. Decker, Lipid oxidation in oil-in-water emulsions: Impact of molecular 
environment on chemical reactions in heterogeneous food systems, J. Food Sci. 65 (2000) 1270–
1282; https://doi.org/10.1111/j.1365-2621.2000.tb10596.x
15.  ‘Stability testing of active pharmaceutical ingredients and finished pharmaceutical products’, in 
953, ed. by World_Health_Organization, 2009, pp. 1–53; http://apps.who.int/medicinedocs/docu-
ments/s19133en/s19133en.pdf; last access date June 12, 2018.
16.  F. H. Xavier-Jr, K. G. H. Silva, I. E. G. Farias, A. R. V. Morais, E. N. Alencar, I. B. Araujo, A. G. 
Oliveira and E. S. T. Egito, Prospective study for the development of emulsion systems containing 
48
R. Rutckeviski et al.: Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability, 
Acta Pharm. 69 (2019) 33–48.
 
natural oil products, J. Drug Deliv. Sci. Technol. 22 (2012) 367–372; https://doi.org/10.1016/S1773-
2247(12)50061-4
17.  C. Jacobsen, M. B. Let, N. S. Nielsen and A. S. Meyer, Antioxidant strategies for preventing oxida-
tive flavour deterioration of foods enriched with n-3 polyunsaturated lipids: a comparative eval-
uation, Trends Food Sci. Technol. 19 (2008) 76–93; https://doi.org/10.1016/j.tifs.2007.08.001
18.  C. C. Berton-Carabin, M.-H. Ropers and C. Genot, Lipid oxidation in oil-in-water emulsions: In-
volvement of the interfacial layer, Compr. Rev. Food Sci. Food Saf. 13 (2014) 945–977; https://doi.
org/10.1111/1541-4337.12097
19.  M. Golding and T. J. Wooster, The influence of emulsion structure and stability on lipid digestion, 
Curr. Opin. Colloid Interface Sci. 15 (2010) 90–101; https://doi.org/10.1016/j.cocis.2009.11.006
20.  R. C. Rowe, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, London 2012; ISBN 978 1 
58212 135 2 (USA)
21.  V. Krstonošić, L. Dokić, P. Dokić and T. Dapčević, Effects of xanthan gum on physicochemical 
properties and stability of corn oil-in-water emulsions stabilized by polyoxyethylene (20) sorbitan 
monooleate, Food Hydrocoll. 23 (2009) 2212–2218; https://doi.org/10.1016/j.foodhyd.2009.05.003
22.  K. Shimada, H. Muta, Y. Nakamura, H. Okada, K. Matsuo, S. Yoshioka, T. Matsudaira and T. Na-
kamura, Iron-binding property and antioxidative activity of xanthan on the autoxidation of soy-
bean oil in emulsion, J. Agric. Food Chem. 42 (1994) 1607–1611; https://doi.org/10.1021/jf00044a004
23.  M. Hatzopoulos, C. James, S. Rogers, I. Grillo, P. Dowding and J. Eastoe, Effects of small ionic 
amphiphilic additives on reverse microemulsion morphology, J. Colloid Interface Sci. 421 (2014) 
56–63; https://doi.org/10.1016/j.jcis.2014.01.024
24.  J. Marcus, S. Wolfrum, D. Touraud and W. Kunz, Influence of high intensity sweeteners and 
sugar alcohols on a beverage microemulsion, J. Colloid Interface Sci. 460 (2015) 105–112; https://doi.
org/10.1016/j.jcis.2015.08.036
25.  T. N. Barradas, V. E. B. Campos, J. P. Senna, C. S. C. Coutinho, B. S. Tebaldi, K. G. d. H. Silva and 
C. R. E. Mansur, Development and characterization of promising o/w nanoemulsions containing 
sweet fennel essential oil and non-ionic sufactants, Colloids Surf. A Physicochem. Eng. Asp. 480 
(2015) 214–221; https://doi.org/10.1016/j.colsurfa.2014.12.001
26.  M. I. G. Rosas, J. M. Castro, L. A. O. Martínez, L. S. Trujillo and O. M. Belloso, Long-term stability 
of food-grade nanoemulsions from high methoxyl pectin containing essential oils, Food Hydrocoll. 
52 (2016) 438–446; https://doi.org/10.1016/j.foodhyd.2015.07.017
27.  S. Mayer, J. Weiss and D. J. McClements, Behavior of vitamin E acetate delivery systems under 
simulated gastrointestinal conditions: Lipid digestion and bioaccessibility of low-energy nano-
emulsions, J. Colloid Interface Sci. 404 (2013) 215–222; https://doi.org/10.1016/j.jcis.2013.04.048
28.  C. Arancibia, N. Riquelme, R. Zúñiga and S. Matiacevich, Comparing the effectiveness of natural 
and synthetic emulsifiers on oxidative and physical stability of avocado oil-based nanoemulsions, 
Innov. Food Sci. Emerg. Technol. 44 (2017) 8–166; https://doi.org/10.1016/j.ifset.2017.06.009
29.  C. Poyato, I. Navarro-Blasco, M. I. Calvo, R. Y. Cavero, I. Astiasarán and D. Ansorena, Oxidative 
stability of O/W and W/O/W emulsions: Effect of lipid composition and antioxidant polarity, Food 
Res. Int. 51 (2013) 132–140; https://doi.org/10.1016/j.foodres.2012.11.032
30.  D. S. Gerding, B. D. Oomah, F. Acevedo, E. Morales, M. Bustamante, C. Shene and M. Rubilar, 
High carotenoid bioaccessibility through linseed oil nanoemulsions with enhanced physical and 
oxidative stability, Food Chem. 199 (2016) 463–470; https://doi.org/10.1016/j.foodchem.2015.12.004
